Lysozyme binding to endocardial endothelium mediates myocardial depression by the nitric oxide guanosine 3′,5′ monophosphate pathway in sepsis

Journal of Molecular and Cellular Cardiology

Volumn 39, Issue 4, 2005, Pages 615-625

  Mink, Steven N ^a   Bose, Ratna ^a   Roberts, Diane E ^a   Jacobs, Hans ^a   Duke, Krika ^a   Bose, Deepak ^a   Cheng, Zhao Qin ^a   Light, R Bruce ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Endothelium; Inflammation; Myocardial depression; Nitric oxide synthase; Shock

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; CYCLIC GMP DEPENDENT PROTEIN KINASE; CYCLIC GMP DEPENDENT PROTEIN KINASE INHIBITOR; FLUORESCENT DYE; GUANYLATE CYCLASE; LYSOZYME; MEMBRANE PROTEIN; N(G) METHYLARGININE; NITRIC OXIDE; PHOSPHATE; TRITON X 100;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ENDOCARDIUM; ENDOTHELIUM; ENZYME ACTIVATION; HEART DISEASE; HEART MUSCLE; HEART MUSCLE CONTRACTILITY; MUSCLE ISOMETRIC CONTRACTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; SEPSIS;

ANIMALS; CELL MEMBRANE; CYCLIC GMP; DOGS; ENDOCARDIUM; ENDOTHELIUM; MURAMIDASE; MYOCARDIAL CONTRACTION; MYOCARDIUM; NITRIC OXIDE; OMEGA-N-METHYLARGININE; OXADIAZOLES; QUINOXALINES; SEPSIS;

CANIS FAMILIARIS; ESCHERICHIA COLI;

EID: 24944561091     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2005.06.009     Document Type: Article

References (34)

1. M.M. Parker, J.H. Shelhamer, S.L. Bacharach, M.V. Green, C. Natanson, and T.M. Frederick Profound but reversible myocardial depression in patients with septic shock Ann. Intern. Med. 100 1984 483 490
2. J.E. Parrillo, C. Burch, J.H. Shelhamer, M.M. Parker, C. Natanson, and W. Schuette A circulating myocardial depressant substance in humans with septic shock J. Clin. Invest. 76 1985 1539 1553
3. A. Gomez, R. Wang, H. Unruh, R.B. Light, D. Bose, and T. Chau Hemofiltration reverses left ventricular dysfunction during sepsis in dogs Anesthesiology 73 1990 671 685
4. S.N. Mink, H. Jacobs, D. Bose, K. Duke, Z.Q. Cheng, and G. Liu Lysozyme: a mediator of myocardial depression and adrenergic dysfunction in septic shock in dogs J. Mol. Cell. Cardiol. 35 2003 265 275
5. D.M. Chipman, and N. Sharon Mechanism of lysozyme action Science 165 1969 454 465
6. A. Fleming On a remarkable bacteriolytic element found in tissue and secretions Proc. R. Soc. Lond. (Biol.) 93 1922 306 307
7. R.S. Briggs, P.E. Perillie, and S.C. Finch Lysozyme in bone marrow and peripheral blood cells J. Histochem. Cytochem. 14 1969 167 170
8. N.E. Hansen, H. Karle, V. Andersen, and K. Ølgaard Lysozyme turnover in man J. Clin. Invest. 51 1972 1146 1155
9. S.N. Mink, H. Jacobs, K. Duke, D. Bose, Z.Q. Cheng, and R.B.N. Light N′,N″ triacetylglucosamine, an inhibitor of lysozyme, prevents myocardial depression in E. coli sepsis in dogs Crit. Care Med. 32 2004 184 193
10. T. Rand-Meir, F.W. Dahlquist, and M.A. Raftery Use of synthetic substrates to study binding and catalysis by lysozyme Biochemistry 8 1969 4206 4214
11. H. Jacobs, S.N. Mink, K. Duke, D. Bose, Z.Q. Cheng, and S. Howlett Characterization of membrane N-glycan binding sites of lysozyme for cardiac depression in sepsis Intensive Care Med. 31 2005 129 137
12. A.M. Shah, and P.A. MacCarthy Paracrine and autocrine effects of nitric oxide on myocardial function Pharmacol. Ther. 86 2000 49 86
13. P.B. Massion, S. Moniotte, and J.L. Balligand Nitric oxide: does it play a role in the heart of the critically ill? Curr. Opin. Crit. Care 7 2001 323 336
14. J. Layland, J.M. Li, and A.M. Shah Role of cyclic GMP-dependent protein kinase in the contractile response to exogenous nitric oxide in rat myocytes J. Physiol. 540 Part 2 2002 457 467
15. L. Kuruvilla, and C.C. Kartha Molecular mechanisms in endothelial regulation of cardiac function Mol. Cell. Biochem. 253 2003 113 123
16. D.L. Brutsaert, P. Fransen, L.J. Andries, G.W. De Keulenaer, and S.U. Sys Cardiac endothelium and myocardial function Cardiovasc. Res. 38 1998 281 290
17. M.S. Finkel, C.V. Oddis, T.D. Jacob, S.C. Watkins, B.G. Hattler, and R.L. Simmons Negative inotropic effects of cytokines on the heart mediated by nitric oxide Science 257 1992 387 389
18. K.M. Bettens, S.G. De Hert, S.U. Sys, and D.L. Brutsaert Role of the endocardial endothelium in the negative inotropic effects of thiopental Anesthesiology 85 1996 1100 1110
19. S.M. Lohmann, A.B. Vaandrager, A. Smolenski, U. Walter, and H.R. De Jonge Distinct and specific functions of cGMP-dependent protein kinases Trends Biochem. Sci. 22 1997 307 312
20. National Institutes of Health Guide for the care and use of laboratory animals 1996 Bethesda, MD: National Institutes of Health (NIH Publication No. 85-23)
21. D. Shugar Measurement of lysozyme activity and the ultra violet inactivation of lysozyme Biochim. Biophys. Acta 8 1952 302 309
22. T. Tatsumi, N. Keira, K. Akashi, M. Kobara, S. Matoba, and J. Shiraishi Nitric oxide-cGMP pathway is involved in endotoxin-induced contractile dysfunction in rat hearts J. Appl. Physiol. 96 2004 853 860
23. L. Caputo, J. Benessiano, C.M. Boulanger, and B.I. Levy Angiotensin II increases cGMP content via endothelial angiotensin II AT1 subtype receptors in the rat carotid artery Arterioscler. Thromb. Vasc. Biol. 15 1995 1646 1651
24. L.J. Andries, D.L. Brutsaert, and S.U. Sys Nonuniformity of endothelial constitutive nitric oxide synthase distribution in cardiac endothelium Circ. Res. 82 1998 195 203
25. M. Boerma, J.J. Kruse, M. van Loenen, H.R. Klein, C.I. Bart, and C. Zurcher Increased deposition of von Willebrand factor in the rat heart after local ionizing irradiation Strahlenther. Onkol. 180 2004 109 116
26. N. Nakatsubo, H. Kojima, K. Kikuchi, H. Nagoshi, Y. Hirata, and D. Maeda Direct evidence of nitric oxide production from bovine aortic endothelial cells using new fluorescence indicators; diaminofluoresceins FEBS Lett. 427 1998 263 266
27. P. Jha, H. Jacobs, D. Bose, R. Wang, J. Yang, R.B. Light, and S. Mink Effects of E. coli sepsis and myocardial depressant factor on interval-force relations in dog ventricle Am. J. Physiol. 264 1993 H1402 H1410 (Heart Circ Physiol 33)
28. R. Schulz, D.L. Panas, R. Catena, S. Moncada, P.M. Olley, and G.D. Lopaschuk The role of nitric oxide in cardiac depression induced by interleukin-1β and tumor necrosis factor -α Br. J. Pharmacol. 114 1995 27 34
29. H. Luss, S.C. Watkins, P.D. Freeswick, A.K. Imro, A.K. Nussler, and T.R. Billiar Characterization of inducible nitric oxide synthase expression in endotoxemic rat cardiac myoctyes in vivo and following cytokine exposure in vitro J. Mol. Cell. Cardiol. 27 1995 2015 2029
30. P.B. Massion, and J.L. Balligand Modulation of cardiac contraction, relaxation and rate by the endothelial nitric oxide synthase (eNOS): lessons from genetically modified mice J. Physiol. 546 Part 1 2003 63 75
31. M. Gu, R. Bose, D. Bose, J. Yang, X. Li, and R.B. Light Tumour necrosis factor-α, but not septic plasma depresses cardiac myofilament contraction Can. J. Anaesth. 45 1998 352 359
32. S.N. Mink, H. Jacobs, K. Duke, D. Bose, Z. Cheng, and R.B.N. Light N′,N″ triacetylglucosamine, an inhibitor of lysozyme prevents myocardial depression in E. coli sepsis in dogs Am. J. Respir. Crit. Med. 169 2004 633 (Abstract)
33. R. Grover, D. Zaccardelli, G. Colice, K. Guntupalli, D. Watson, and J.L. Vincent An open label dose escalation study of the nitric oxide synthase inhibitor, N(G) methyl-l-arginine hydrochloride (546C88) in patients with septic shock. Glaxo Wellcome International Septic Shock Study Group Crit. Care Med. 27 1999 913 922
34. P. Burgess, S.H. Appel, C.A. Wilson, and H.C. Polk Jr. Detection of intraabdominal abscess by serum lysozyme estimation Surgery 115 1994 16 21